医学
肾
肾单位
肾脏疾病
盐皮质激素受体
糖尿病
内分泌学
醛固酮
内科学
蛋白尿
封锁
肾素-血管紧张素系统
2型糖尿病
受体
血压
作者
Anna Gaddy,Mohamed E. Elrggal,Hector Madariaga,Adam Kelly,Edgar V. Lerma,Gates B. Colbert
标识
DOI:10.1016/j.disamonth.2024.101848
摘要
Diabetic kidney disease is a leading cause of kidney failure worldwide and is easily detectable with screening examination. Diabetes causes hyperfiltration and activation of the renin-angiotensin aldosterone system by hemodynamic changes within the nephron, which perpetuates damaging physiology. Diagnosis is often clinical after detection of heavy proteinuria in a patient with diabetes,but can be confirmed by observation of histologic stages on kidney biopsy. Mainstays of treatment include angiotensin conversion or receptor blockade, mineralocorticoid receptor blockade, and tight glucose control. Newer agents favored in diabetic kidney disease are sodium glucose-cotransporters and glucagon-like peptide 1 receptor agonists, both for glycemic control and for various methods of reversing damaging physiology.
科研通智能强力驱动
Strongly Powered by AbleSci AI